Excited to share our new NIH/ORWH-funded $12.8 million, three-year project to understand how dynamic hormones influence women’s drug efficacy and safety. Dr. Xiao serves as an MPI with Teresa K. … Read More
Wildfires have become more frequent and intense, and this trend is only projected to continue in the coming years. The Xiao Lab is excited to receive a new NIH R01 … Read More
Sonia (Yunman) Song, a PharmD/PhD student from the Xiao Lab, published her first first-author paper in BOR reviewing the mechanistic roles of DNA damage response (DDR) in contributing primary ovarian … Read More
A new EHP paper from our group indicated that exposure to environmentally high but still human relevant exposure levels of PFNA, an understudied PFAS, exhibits ovarian disrupting effects by interfering … Read More
Shuo, Sonia, and Kuhelika Samantha and Shuo
SOT Interview on YouTube: https://www.youtube.com/watch?v=aEbOixgtSak
Dr. Xiao recently received a new 5-year/$3 million R01 grant from NIEHS to study the ovarian disrupting effects of forever chemical PFAS and mixtures. PFAS have been extensively used in … Read More
Dr. Xiao, in collaboration with Dr. So-Youn Kim from the University of Nebraska Medical Center (UNMC), recently received a new 5-year/$3.2 million R01 grant from NICHD to study the molecular … Read More
Dr. Xiao received the SSR Virendra B. Mahesh New Investigator Award. The Award was presented at the SSR Annual Meeting in Dublin, Ireland in July 15-19, 2024. Dr. Xiao also … Read More
In collaboration with Dr Xiaoqin Ye from UGA and Dr. James Segars, Dr. Xiao and his team is awarded their 2nd R01 grant from NICHD to use their organ-on-chip model … Read More